Solid Financial Results Driven by Long-Term Diversification of the Business
LISLE, Ill., Oct. 27, 2021 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) today announced third quarter 2021 results.
- Sales were $122.4 million, up 8% year-over-year. Sales to non-transportation end markets increased 24%, and sales to transportation end market decreased 5%. The Sensor Scientific acquisition added $1.8 million of sales in the third quarter of 2021.
- Net loss was $63.9 million, or $(1.97) per diluted share, versus $11.1 million, or $0.34 per diluted share, in the third quarter of last year. The third quarter net earnings were impacted by a non-cash charge of $76 million, net of taxes related to the previously disclosed termination of the U.S. pension plan.
- Adjusted diluted EPS was $0.46, up from $0.34 in the third quarter of 2020.
- Free cash flow was $17.2 million, down from $22.4 million in the third quarter of 2020.
- New business wins were $179 million.
“We continued to advance our diversification strategy during the third quarter, with non-transportation related revenue closer to 50% of total revenue for the quarter. Further, our third quarter results demonstrated the differentiation of our product portfolio, as well as the richness of our customer base, which allowed us to deliver growth ahead of the industry, despite a challenging supply chain environment. As we look forward, we believe the strong execution of our team, coupled with a robust pipeline will allow us to continue to capitalize on the opportunities in the industrial, medical, aerospace and defense end markets,” said Kieran O’Sullivan, CEO of CTS Corporation.
2021 Guidance
While management remains mindful of supply chain uncertainties, CTS has raised and narrowed its 2021 guidance for sales to $495 – $505 million from $480 – $500 million and for adjusted diluted EPS to $1.85 – $1.95 from $1.70 – $1.90.
Conference Call
As previously announced, the Company has scheduled a conference call at 10:00 a.m. (EST) today to discuss the third quarter financial results. The dial-in number is 800-309-1256 (323-347-3622, if calling from outside the U.S.). The passcode is 572446. A replay of the conference call will be available from 1:00 p.m. (EST) on Wednesday, October 27, 2021 through 1:00 p.m. (EST) on Wednesday, November 10, 2021. The telephone number for the replay is 888-203-1112 (719-457-0820, if calling from outside the U.S.). The replay passcode is 6028607. A live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation at www.ctscorp.com.
About CTS
CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, telecommunications/IT, and transportation markets. For more information, visit www.ctscorp.com.
Safe Harbor
This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect our current expectations concerning future results and events, and any other statements that are not based solely on historical fact. Forward-looking statements are based on management's expectations, certain assumptions and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties and other factors, which could cause our actual results, performance or achievements to differ materially from those presented in the forward-looking statements. Many of these, and other, risks and uncertainties are discussed in further detail in Item 1A. of CTS’ Annual Report on Form 10-K. We undertake no obligation to publicly update our forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.
Contact
Ashish Agrawal
Vice President and Chief Financial Officer
CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532
USA
Telephone: +1 (630) 577-8800
E-mail: ashish.agrawal@ctscorp.com
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) EARNINGS - UNAUDITED
(In thousands of dollars, except per share amounts)
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30,
2021 |
|
|
September 30,
2020 |
|
|
September 30,
2021 |
|
|
September 30,
2020 |
|
| Net sales |
|
$ |
122,382 |
|
|
$ |
113,777 |
|
|
$ |
380,394 |
|
|
$ |
301,049 |
|
| Cost of goods sold |
|
|
76,720 |
|
|
|
76,871 |
|
|
|
244,446 |
|
|
|
204,677 |
|
| Gross margin |
|
|
45,662 |
|
|
|
36,906 |
|
|
|
135,948 |
|
|
|
96,372 |
|
| Selling, general and administrative expenses |
|
|
19,922 |
|
|
|
16,883 |
|
|
|
59,184 |
|
|
|
48,310 |
|
| Research and development expenses |
|
|
6,454 |
|
|
|
5,723 |
|
|
|
18,170 |
|
|
|
18,653 |
|
| Restructuring charges |
|
|
319 |
|
|
|
1,041 |
|
|
|
551 |
|
|
|
1,416 |
|
| Operating earnings |
|
|
18,967 |
|
|
|
13,259 |
|
|
|
58,043 |
|
|
|
27,993 |
|
| Other (expense) income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest expense |
|
|
(514 |
) |
|
|
(857 |
) |
|
|
(1,577 |
) |
|
|
(2,617 |
) |
| Interest income |
|
230 |
|
|
217 |
|
|
689 |
|
|
852 |
|
| Other (expense) income, net |
|
|
(108,502 |
) |
|
|
1,617 |
|
|
|
(132,786 |
) |
|
|
(109 |
) |
| Total other expense, net |
|
|
(108,786 |
) |
|
977 |
|
|
|
(133,674 |
) |
|
|
(1,874 |
) |
| (Loss) earnings before income taxes |
|
|
(89,819 |
) |
|
|
14,236 |
|
|
|
(75,631 |
) |
|
|
26,119 |
|
| Income tax expense |
|
|
(25,923 |
) |
|
|
3,163 |
|
|
|
(24,600 |
) |
|
|
6,381 |
|
| Net (loss) earnings |
|
|
(63,896 |
) |
|
|
11,073 |
|
|
|
(51,031 |
) |
|
$ |
19,738 |
|
| Earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
$ |
(1.97 |
) |
|
$ |
0.34 |
|
|
$ |
(1.58 |
) |
|
$ |
0.61 |
|
| Diluted |
|
$ |
(1.97 |
) |
|
$ |
0.34 |
|
|
$ |
(1.58 |
) |
|
$ |
0.61 |
|
| Basic weighted – average common shares outstanding: |
|
|
32,379 |
|
|
|
32,268 |
|
|
|
32,365 |
|
|
|
32,331 |
|
| Effect of dilutive securities |
|
|
— |
|
|
241 |
|
|
|
— |
|
|
270 |
|
| Diluted weighted – average common shares outstanding: |
|
|
32,379 |
|
|
|
32,509 |
|
|
|
32,365 |
|
|
|
32,601 |
|
| Cash dividends declared per share |
|
$ |
0.04 |
|
|
$ |
0.04 |
|
|
$ |
0.12 |
|
|
$ |
0.12 |
|
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands of dollars)
|
|
(Unaudited) |
|
|
|
|
|
|
|
September 30, 2021 |
|
|
December 31, 2020 |
|
| ASSETS |
|
|
|
|
|
|
|
|
| Current Assets |
|
|
|
|
|
|
|
|
| Cash and cash equivalents |
|
$ |
128,527 |
|
|
$ |
91,773 |
|
| Accounts receivable, net |
|
|
78,210 |
|
|
|
80,981 |
|
| Inventories, net |
|
|
50,867 |
|
|
|
45,870 |
|
| Other current assets |
|
|
19,845 |
|
|
|
14,607 |
|
| Total current assets |
|
|
277,449 |
|
|
|
233,231 |
|
| Property, plant and equipment, net |
|
|
92,533 |
|
|
|
97,437 |
|
| Operating lease assets, net |
|
|
22,456 |
|
|
|
23,281 |
|
| Other Assets |
|
|
|
|
|
|
|
|
| Prepaid pension asset |
|
|
50,638 |
|
|
|
56,642 |
|
| Goodwill |
|
|
109,798 |
|
|
|
109,497 |
|
| Other intangible assets, net |
|
|
72,236 |
|
|
|
79,121 |
|
| Deferred income taxes |
|
|
24,663 |
|
|
|
24,250 |
|
| Other |
|
|
2,200 |
|
|
|
2,590 |
|
| Total other assets |
|
|
259,535 |
|
|
|
272,100 |
|
| Total Assets |
|
$ |
651,973 |
|
|
$ |
626,049 |
|
| LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
| Current Liabilities |
|
|
|
|
|
|
|
|
| Accounts payable |
|
$ |
48,976 |
|
|
$ |
50,489 |
|
| Operating lease obligations |
|
|
3,354 |
|
|
|
3,294 |
|
| Accrued payroll and benefits |
|
|
17,069 |
|
|
|
12,978 |
|
| Accrued expenses and other liabilities |
|
|
35,673 |
|
|
|
38,171 |
|
| Total current liabilities |
|
|
105,072 |
|
|
|
104,932 |
|
| Long-term debt |
|
|
50,000 |
|
|
|
54,600 |
|
| Long-term operating lease obligations |
|
|
22,262 |
|
|
|
23,163 |
|
| Long-term pension obligations |
|
|
7,114 |
|
|
|
7,466 |
|
| Deferred income taxes |
|
|
6,907 |
|
|
|
7,010 |
|
| Other long-term obligations |
|
|
3,244 |
|
|
|
5,196 |
|
| Total Liabilities |
|
|
194,599 |
|
|
|
202,367 |
|
| Commitments and Contingencies |
|
|
|
|
|
|
|
|
| Shareholders’ Equity |
|
|
|
|
|
|
|
|
| Common stock |
|
|
314,351 |
|
|
|
311,190 |
|
| Additional contributed capital |
|
|
40,958 |
|
|
|
41,654 |
|
| Retained earnings |
|
|
484,368 |
|
|
|
539,281 |
|
| Accumulated other comprehensive loss |
|
|
(4,842 |
) |
|
|
(95,921 |
) |
| Total shareholders’ equity before treasury stock |
|
|
834,835 |
|
|
|
796,204 |
|
| Treasury stock |
|
|
(377,461 |
) |
|
|
(372,522 |
) |
| Total shareholders’ equity |
|
|
457,374 |
|
|
|
423,682 |
|
| Total Liabilities and Shareholders’ Equity |
|
$ |
651,973 |
|
|
$ |
626,049 |
|
CTS CORPORATION AND SUBSIDIARIES
OTHER SUPPLEMENTAL INFORMATION - UNAUDITED
Earnings Per Share
The following table reconciles GAAP diluted (loss) earnings per share to adjusted diluted earnings per share for the Company:
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30,
2021 |
|
|
September 30,
2020 |
|
|
September 30,
2021 |
|
|
September 30,
2020 |
|
| GAAP diluted (loss) earnings per share |
|
$ |
(1.97 |
) |
|
$ |
0.34 |
|
|
$ |
(1.58 |
) |
|
$ |
0.61 |
|
| Tax affected charges to reported diluted (loss) earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restructuring charges |
|
|
0.01 |
|
|
|
0.03 |
|
|
|
0.02 |
|
|
|
0.04 |
|
| Foreign currency (gain) loss |
|
|
0.03 |
|
|
|
(0.07 |
) |
|
|
0.04 |
|
|
|
(0.06 |
) |
| Non-cash pension expense |
|
|
2.54 |
|
|
|
0.01 |
|
|
|
3.10 |
|
|
|
0.04 |
|
| Environmental charges |
|
|
0.01 |
|
|
|
0.01 |
|
|
|
0.02 |
|
|
|
0.03 |
|
| Discrete tax items |
|
|
(0.16 |
) |
|
|
0.02 |
|
|
|
(0.16 |
) |
|
|
0.03 |
|
| Adjusted diluted earnings per share |
|
$ |
0.46 |
|
|
$ |
0.34 |
|
|
$ |
1.44 |
|
|
$ |
0.69 |
|
Free Cash Flow
The following table reconciles GAAP operating cash flow to free cash flow for the Company:
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30,
2021 |
|
|
September 30,
2020 |
|
|
September 30,
2021 |
|
|
September 30,
2020 |
|
| Net cash provided by operating activities |
|
$ |
21,332 |
|
|
$ |
25,573 |
|
|
$ |
60,117 |
|
|
$ |
49,297 |
|
| Capital expenditures |
|
|
(4,170 |
) |
|
|
(3,196 |
) |
|
|
(8,140 |
) |
|
|
(10,441 |
) |
| Free cash flow |
|
$ |
17,162 |
|
|
$ |
22,377 |
|
|
$ |
51,977 |
|
|
$ |
38,856 |
|
Additional Information
The following table includes other financial information not presented in the preceding financial statements.
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30,
2021 |
|
|
September 30,
2020 |
|
|
September 30,
2021 |
|
|
September 30,
2020 |
|
| Depreciation and amortization expense |
|
$ |
6,719 |
|
|
$ |
6,676 |
|
|
$ |
20,231 |
|
|
$ |
19,819 |
|
| Stock-based compensation expense |
|
$ |
987 |
|
|
$ |
1,119 |
|
|
$ |
4,106 |
|
|
$ |
2,164 |
|
Non-GAAP Financial Measures
From time to time, CTS may use non-GAAP financial measures in discussing CTS’ business. These measures are intended to supplement, not replace, CTS’ presentation of its financial results in accordance with GAAP. CTS’ management believes that non-GAAP financial measures can be useful to investors in analyzing CTS’ financial performance and results of operations over time. CTS recommends that investors consider both actual and adjusted measures in evaluating the performance of CTS with peer companies.
Adjusted Diluted Earnings Per Share
Adjusted diluted earnings per share is a non-GAAP financial measure. The most directly comparable GAAP financial measure is diluted (loss) earnings per share.
CTS uses an adjusted earnings per share measure to evaluate overall performance, establish plans and perform strategic analysis. Using this measure avoids distortion in the evaluation of operating results by eliminating the impact of events which are not related to normal operating performance. Because this measure is based on the exclusion or inclusion of specific items, they may not be comparable to measures used by other companies which have similar titles. CTS' management compensates for this limitation when performing peer comparisons by evaluating both GAAP and non-GAAP financial measures reported by peer companies. CTS believes that this measure is useful to its management, investors and stakeholders in that it:
- provides a meaningful measure of CTS' operating performance,
- reflects the results used by management in making decisions about the business, and
- helps review and project CTS' performance over time.
Free Cash Flow
Free cash flow is a non-GAAP financial measure. The most directly comparable GAAP financial measure is net cash provided by operating activities. CTS believes free cash flow is a useful measure of its ability to generate cash.
